Hospital
The Fort Hamilton Hospital
The Fort Hamilton Hospital was paid $27.06M by Medicaid between Jan 2018 and Dec 2024, across 302 billing codes. Its largest line is 99283, emergency room visit (moderate) — 22% of everything it billed.
33Billing provider infoTHE FORT HAMILTON HOSPITAL
HAMILTON, OH 45013
HAMILTON, OH 45013
33aNPI1104867167assigned 06/09/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$27.06M
24GClaims655,802
24DCodes billed302
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Ohio
Rank by total paid#43 of 101
Median peer was paid$22.32M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official KO, TIMOTHY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 71,187 | $2.55M | |
| 2019 | 57,548 | $2.34M | |
| 2020 | 49,348 | $2.76M | |
| 2021 | 58,304 | $2.95M | |
| 2022 | 67,902 | $3.33M | |
| 2023 | 193,572 | $7.80M | |
| 2024incomplete | 157,941 | $5.33M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 50,394 | 46,648 | $5.92M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 28,904 | 26,890 | $3.92M |
| 96361 | Intravenous infusion, hydration; each additional hour | 13% | 11,435 | 8,684 | $3.54M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.1% | 11,699 | 10,426 | $1.65M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 5.0% | 17,255 | 5,250 | $1.35M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3.3% | 10,646 | 7,671 | $890K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.9% | 7,187 | 6,792 | $777K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 2.2% | 7,001 | 3,127 | $608K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.0% | 2,353 | 1,955 | $551K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.0% | 3,281 | 1,961 | $542K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.0% | 2,198 | 1,871 | $536K |
| G0378 | Hospital observation service, per hour | 1.5% | 5,674 | 3,096 | $416K |
290 more codes
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.5% | 1,110 | $408K |
| 11043 | 1.2% | 1,402 | $328K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.2% | 1,177 | $320K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.2% | 1,580 | $314K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,449 | $261K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 25,069 | $238K |
| 11045 | <1% | 998 | $227K | |
| 80053 | Comprehensive metabolic panel | <1% | 30,459 | $223K |
| 93356 | <1% | 798 | $213K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 5,003 | $190K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 675 | $175K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 387 | $165K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,360 | $160K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 999 | $156K |
| 59025 | Fetal non-stress test | <1% | 969 | $153K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,257 | $138K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 8,255 | $133K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,106 | $130K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 314 | $124K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 6,253 | $88K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,778 | $84K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 362 | $79K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 448 | $73K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 56,611 | $72K |
| 84484 | <1% | 17,196 | $67K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 589 | $60K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,038 | $57K |
| 80061 | Lipid panel | <1% | 3,916 | $55K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 168 | $53K |
| 43248 | <1% | 174 | $43K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,957 | $43K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,763 | $43K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,554 | $43K |
| 80076 | <1% | 7,889 | $42K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 26,562 | $41K |
| 12001 | <1% | 255 | $41K | |
| 97162 | <1% | 1,083 | $40K | |
| 95886 | <1% | 141 | $38K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 20,315 | $35K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 284 | $35K |
| 76642 | <1% | 215 | $31K | |
| 73221 | <1% | 158 | $30K | |
| 93017 | <1% | 383 | $30K | |
| 71045 | Radiologic examination, chest; single view | <1% | 11,974 | $30K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,673 | $30K |
| 82805 | <1% | 1,052 | $29K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 173 | $29K |
| 71250 | <1% | 282 | $27K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 2,217 | $26K |
| 76830 | Ultrasound, transvaginal | <1% | 355 | $26K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,319 | $25K |
| 97161 | <1% | 547 | $25K | |
| 82607 | <1% | 1,556 | $24K | |
| 10060 | <1% | 140 | $23K | |
| 29580 | <1% | 237 | $20K | |
| 97607 | <1% | 198 | $18K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 826 | $16K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 637 | $16K |
| 86850 | <1% | 839 | $16K | |
| 93971 | <1% | 205 | $16K | |
| 95811 | <1% | 27 | $16K | |
| 94060 | <1% | 116 | $16K | |
| 80069 | <1% | 1,185 | $16K | |
| 85027 | <1% | 4,478 | $15K | |
| 97166 | <1% | 386 | $15K | |
| J3490 | Unclassified drugs | <1% | 4,035 | $15K |
| 72100 | <1% | 598 | $15K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 117 | $14K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 886 | $14K |
| 96367 | <1% | 761 | $14K | |
| 84100 | <1% | 1,924 | $13K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 26 | $13K |
| 29581 | <1% | 137 | $13K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 9,612 | $13K |
| 83735 | <1% | 5,656 | $13K | |
| 86900 | <1% | 1,079 | $12K | |
| 97165 | <1% | 254 | $12K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 45 | $12K |
| 73030 | <1% | 832 | $11K | |
| 84439 | <1% | 765 | $11K | |
| 90715 | <1% | 661 | $10K | |
| 82746 | <1% | 1,405 | $10K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 16,220 | $10K |
| 93970 | <1% | 84 | $9K | |
| 70496 | <1% | 44 | $9K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 8,170 | $9K |
| 81001 | <1% | 18,948 | $9K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 41 | $8K |
| 86803 | <1% | 382 | $8K | |
| 73130 | <1% | 751 | $8K | |
| 82728 | <1% | 1,651 | $8K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 676 | $8K |
| 76770 | <1% | 69 | $8K | |
| 94726 | <1% | 109 | $8K | |
| 94729 | <1% | 111 | $8K | |
| 73562 | <1% | 697 | $8K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 36 | $7K |
| 76801 | <1% | 38 | $7K | |
| 93270 | <1% | 73 | $7K | |
| 72040 | <1% | 162 | $7K | |
| 73630 | <1% | 845 | $6K | |
| 36591 | <1% | 1,672 | $6K | |
| 83540 | <1% | 1,505 | $6K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 29 | $6K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 10,462 | $6K |
| 72131 | <1% | 116 | $5K | |
| 80320 | <1% | 454 | $5K | |
| 84436 | <1% | 592 | $5K | |
| 93880 | <1% | 72 | $5K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 583 | $5K |
| 97597 | <1% | 296 | $5K | |
| 86140 | <1% | 657 | $5K | |
| 83550 | <1% | 1,476 | $5K | |
| 96376 | <1% | 1,906 | $5K | |
| 73502 | <1% | 373 | $5K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 27 | $4K |
| 85610 | <1% | 2,566 | $4K | |
| 73610 | <1% | 744 | $4K | |
| 12011 | <1% | 36 | $4K | |
| 87529 | <1% | 1,402 | $4K | |
| 83880 | <1% | 1,608 | $4K | |
| 93975 | <1% | 27 | $4K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 26 | $4K |
| 80324 | <1% | 143 | $4K | |
| 73110 | <1% | 542 | $4K | |
| 74018 | <1% | 186 | $3K | |
| 82575 | <1% | 336 | $3K | |
| 83605 | <1% | 3,008 | $3K | |
| 87634 | <1% | 1,291 | $3K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 340 | $3K |
| 73080 | <1% | 263 | $3K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 887 | $3K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,288 | $2K |
| 84702 | <1% | 918 | $2K | |
| 43249 | <1% | 12 | $2K | |
| 73560 | <1% | 242 | $2K | |
| 83690 | <1% | 8,284 | $2K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 833 | $2K |
| 86901 | <1% | 1,078 | $2K | |
| 70491 | <1% | 18 | $2K | |
| 87522 | Neg quan hep c or qual rna | <1% | 80 | $2K |
| 81025 | <1% | 6,956 | $2K | |
| 75635 | <1% | 12 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 887 | $2K |
| 85651 | <1% | 977 | $2K | |
| 85007 | <1% | 929 | $2K | |
| 97116 | <1% | 109 | $2K | |
| 80361 | <1% | 143 | $2K | |
| 84153 | <1% | 125 | $2K | |
| 82043 | <1% | 283 | $2K | |
| 84156 | <1% | 366 | $2K | |
| 77066 | Tomosynthesis, mammo | <1% | 59 | $2K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 78 | $2K |
| 93225 | <1% | 25 | $2K | |
| 77065 | Tomosynthesis, mammo | <1% | 59 | $2K |
| 80348 | <1% | 143 | $2K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 15 | $2K |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 2,357 | $2K |
| 80373 | <1% | 143 | $2K | |
| 72141 | <1% | 13 | $2K | |
| 80354 | <1% | 143 | $2K | |
| 80346 | <1% | 143 | $2K | |
| 70486 | <1% | 81 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,933 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,089 | $2K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 73 | $2K |
| 80372 | <1% | 143 | $2K | |
| 80353 | <1% | 143 | $2K | |
| 81003 | <1% | 2,652 | $2K | |
| 80365 | <1% | 143 | $1K | |
| 80359 | <1% | 143 | $1K | |
| 80358 | <1% | 143 | $1K | |
| 71101 | <1% | 169 | $1K | |
| 87070 | <1% | 2,452 | $1K | |
| 85378 | <1% | 2,026 | $1K | |
| 01999 | <1% | 535 | $1K | |
| 87077 | <1% | 2,063 | $1K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 76 | $1K |
| 84703 | <1% | 2,973 | $1K | |
| 76536 | <1% | 12 | $1K | |
| 87186 | <1% | 1,741 | $869.91 | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 20 | $866.09 |
| 29125 | <1% | 397 | $816.08 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,095 | $785.55 |
| 87210 | <1% | 477 | $706.96 | |
| 87205 | <1% | 1,869 | $704.42 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,397 | $672.22 |
| J2704 | Injection, propofol, 10 mg | <1% | 2,222 | $654.09 |
| 82550 | <1% | 452 | $621.21 | |
| 85730 | <1% | 911 | $607.16 | |
| 72128 | <1% | 14 | $591.19 | |
| 93226 | <1% | 18 | $588.72 | |
| 80074 | <1% | 54 | $578.84 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 4,206 | $564.90 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 7,190 | $541.90 |
| 73590 | <1% | 123 | $533.02 | |
| 84145 | <1% | 920 | $514.82 | |
| 86780 | <1% | 52 | $485.97 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,701 | $467.48 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,606 | $453.27 |
| 82140 | <1% | 162 | $452.31 | |
| 92610 | <1% | 13 | $440.34 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,746 | $409.55 |
| 87040 | <1% | 1,328 | $399.63 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 13,598 | $398.88 |
| 70498 | <1% | 43 | $393.84 | |
| 85014 | <1% | 40 | $392.76 | |
| 88304 | <1% | 221 | $378.92 | |
| G0008 | Administration of influenza virus vaccine | <1% | 36 | $362.15 |
| 01400 | <1% | 83 | $361.08 | |
| 97598 | <1% | 30 | $356.85 | |
| 73140 | <1% | 34 | $344.13 | |
| 86706 | <1% | 31 | $323.39 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 1,073 | $270.47 |
| 86334 | <1% | 56 | $265.97 | |
| 88342 | <1% | 987 | $262.87 | |
| 84132 | <1% | 497 | $258.04 | |
| 73090 | <1% | 67 | $254.39 | |
| 82248 | <1% | 83 | $251.18 | |
| 82950 | <1% | 28 | $244.99 | |
| 83970 | <1% | 12 | $207.20 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 964 | $200.71 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 440 | $199.79 |
| 85018 | <1% | 40 | $196.72 | |
| 72170 | <1% | 146 | $194.47 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 440 | $169.56 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 628 | $160.39 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 1,353 | $156.28 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 1,160 | $150.75 |
| 86592 | <1% | 14 | $147.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,055 | $143.49 |
| 94760 | <1% | 1,204 | $140.58 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 315 | $133.64 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 141 | $131.48 |
| 86141 | <1% | 78 | $126.13 | |
| 84550 | <1% | 85 | $125.36 | |
| 82378 | <1% | 264 | $109.08 | |
| 83615 | <1% | 77 | $92.47 | |
| 84165 | <1% | 58 | $88.65 | |
| 82570 | <1% | 15 | $81.68 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,512 | $80.82 |
| 87486 | <1% | 26 | $74.00 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 893 | $72.88 |
| 82010 | <1% | 158 | $68.78 | |
| 87176 | <1% | 89 | $56.96 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 115 | $46.66 |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | <1% | 494 | $46.23 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 202 | $45.35 |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 198 | $39.46 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 566 | $37.65 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 27 | $37.00 |
| 87581 | <1% | 26 | $37.00 | |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 231 | $29.36 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 77 | $29.23 |
| J3360 | Injection, diazepam, up to 5 mg | <1% | 157 | $26.96 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 789 | $25.85 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 231 | $24.39 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 562 | $23.15 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 39 | $18.28 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 135 | $12.86 |
| J7999 | Compounded drug, not otherwise classified | <1% | 28 | $11.60 |
| J2800 | Injection, methocarbamol, up to 10 ml | <1% | 13 | $8.59 |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 147 | $8.57 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 67 | $8.34 |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 79 | $4.50 |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 60 | $3.86 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 12 | $2.46 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 184 | $2.05 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | <1% | 472 | $0.29 |
| Q0177 | Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 31 | $0.15 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 270 | $0.00 |
| 00731 | 0% | 287 | $0.00 | |
| 00811 | 0% | 98 | $0.00 | |
| 00840 | 0% | 16 | $0.00 | |
| C1776 | Joint device (implantable) | 0% | 79 | $0.00 |
| J1953 | Injection, levetiracetam, 10 mg | 0% | 14 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 17 | $0.00 |
| 36592 | 0% | 17 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 42 | $0.00 |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 0% | 14 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 315 | $0.00 |
| 88311 | 0% | 77 | $0.00 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 199 | $0.00 |
| 94761 | 0% | 216 | $0.00 | |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 77 | $0.00 |
| 00813 | 0% | 128 | $0.00 | |
| C1769 | Guide wire | 0% | 152 | $0.00 |
| C1889 | Implantable/insertable device, not otherwise classified | 0% | 22 | $0.00 |
| 00790 | 0% | 18 | $0.00 | |
| 74022 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKO, TIMOTHY (KETTERING HEALTH CFO)
| Provider | Location | Paid |
|---|---|---|
| Dayton Osteopathic Hospital | Dayton, OH | $111.27M |
| Alliance Physicians INC | Kettering, OH | $38.76M |
| Kettering Medical Center | Kettering, OH | $37.96M |
| Beavercreek Medical Center | Beavercreek, OH | $30.49M |
| Kettering Medical Center | Miamisburg, OH | $20.00M |
| Greene Memorial Hospital INC | Xenia, OH | $11.31M |
| Kettering Medical Center | Troy, OH | $10.83M |
| Kettering Independent Medical Group INC | Miamisburg, OH | $8.39M |
| Kettering Affiliated Health Services | Miamisburg, OH | $2.12M |
| Greene Memorial Hospital, INC. | Jamestown, OH | $1.53M |
| Alliance Physicians INC | Moraine, OH | $1.42M |
| Alliance Physicians INC | Huber Heights, OH | $1.06M |
| Greene Memorial Hospital INC | Yellow Springs, OH | $843K |
| Alliance Physicians INC | Miamisburg, OH | $744K |
| Greene Memorial Hospital INC | Cedarville, OH | $703K |
| Alliance Physicians INC | Xenia, OH | $645K |
| Alliance Physicians INC | Springboro, OH | $616K |
| Alliance Physicians INC | Kettering, OH | $599K |
| Sycamore Primary Care Group | Miamisburg, OH | $564K |
| Alliance Physicians INC | Beavercreek, OH | $486K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.